...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
AGORACOM NEWS FLASH

ATTENTION MEMBERS: 

Tonight, we're giving our website a serious makeover.  

So if you can't access the site for a bit, don't worry, we're just sprucing things up for an even smoother experience.  

In the event that you experience issues accessing the new site, please clear your browser's cookies and cache. 

See You On The Other Side!

Message: Epigenetics market size

https://finance.yahoo.com/news/epigenetics-market-expected-reach-4-123000921.html

 

https://markets.businessinsider.com/news/stocks/epigenetics-market-to-reach-usd-19-12-billion-by-2026-reports-and-data-1028604293

 

 

Interesting that the entire market values  for Epigenetics has fallen from an expected   $19.12 Billon 2019 to $4.3 Billin  in 2026 and not a whisper of  a name from Zenith or Resverlogix. ....  

Still waiting for that allusive deal...

DM where's your 8 year lead ....... your management skills are as good as your academic qualifications 

 

 

 

 

Share
New Message
Please login to post a reply